1. Home
  2. HWKN vs WVE Comparison

HWKN vs WVE Comparison

Compare HWKN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HWKN
  • WVE
  • Stock Information
  • Founded
  • HWKN 1938
  • WVE 2012
  • Country
  • HWKN United States
  • WVE Singapore
  • Employees
  • HWKN N/A
  • WVE N/A
  • Industry
  • HWKN Specialty Chemicals
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HWKN Consumer Discretionary
  • WVE Health Care
  • Exchange
  • HWKN Nasdaq
  • WVE Nasdaq
  • Market Cap
  • HWKN 2.4B
  • WVE 2.4B
  • IPO Year
  • HWKN N/A
  • WVE 2015
  • Fundamental
  • Price
  • HWKN $123.60
  • WVE $13.67
  • Analyst Decision
  • HWKN Hold
  • WVE Strong Buy
  • Analyst Count
  • HWKN 1
  • WVE 10
  • Target Price
  • HWKN $122.00
  • WVE $21.30
  • AVG Volume (30 Days)
  • HWKN 136.9K
  • WVE 1.4M
  • Earning Date
  • HWKN 10-30-2024
  • WVE 11-12-2024
  • Dividend Yield
  • HWKN 0.58%
  • WVE N/A
  • EPS Growth
  • HWKN 18.72
  • WVE N/A
  • EPS
  • HWKN 3.91
  • WVE N/A
  • Revenue
  • HWKN $934,424,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • HWKN $5.61
  • WVE N/A
  • Revenue Next Year
  • HWKN $7.54
  • WVE N/A
  • P/E Ratio
  • HWKN $31.64
  • WVE N/A
  • Revenue Growth
  • HWKN N/A
  • WVE N/A
  • 52 Week Low
  • HWKN $54.44
  • WVE $3.50
  • 52 Week High
  • HWKN $135.61
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • HWKN 54.00
  • WVE 50.96
  • Support Level
  • HWKN $122.56
  • WVE $14.95
  • Resistance Level
  • HWKN $128.93
  • WVE $16.71
  • Average True Range (ATR)
  • HWKN 4.74
  • WVE 1.04
  • MACD
  • HWKN 1.25
  • WVE -0.28
  • Stochastic Oscillator
  • HWKN 82.36
  • WVE 14.72

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: